Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07076342
Recruiting
The Role of mGluR5 in CBT-I
Phase 4 · United States · 1 site
Registry update: 10 Nov 2026
NCT06736028
Recruiting
Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity
Not applicable · United States · 1 site
Registry update: 7 Apr 2026
NCT07085169
Recruiting
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Phase 2 · China · 2 sites
Registry update: 25 Jul 2025
NCT06731049
Recruiting
Comparison of the Effectiveness of Treadmill-Based Walking and Dual-Task Walking Training in Alzheimer's Disease
Not applicable · 1 site
Registry update: 31 Mar 2026
NCT07319312
Recruiting
Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania
Not applicable · Tanzania · 1 site
Registry update: 6 Jan 2026
NCT07625917
Recruiting
Feasibility of Internet-based HIV Prevention Research
Not applicable · United States · 1 site
Registry update: 4 Jun 2026
NCT06906874
Recruiting
Activated Charcoal Use in Chronic Kidney Disease Patients
Phase 2 · Egypt · 1 site
Registry update: 8 Aug 2025
NCT07154316
Recruiting
Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer
Phase 2 · China · 5 sites
Registry update: 4 Sept 2025
NCT07061704
Recruiting
Oncolytic Virus in Esophageal Squamous Cell Carcinoma
Phase 1/2 · China · 1 site
Registry update: 8 Dec 2025
NCT07314723
Recruiting
9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
Phase 2 · China · 1 site
Registry update: 2 Jan 2026
NCT06976892
Recruiting
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
Phase 1 · United Kingdom · 3 sites
Registry update: 13 Aug 2025
NCT07493629
Recruiting
Immune Status and Disease Control of Inflammatory Airway Diseases
Not applicable · China · 1 site
Registry update: 25 Mar 2026
NCT06954116
Recruiting
Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Phase 2 · China · 1 site
Registry update: 18 Sept 2026
NCT07118813
Recruiting
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Not applicable · China · 1 site
Registry update: 12 Aug 2025
NCT07105579
Recruiting
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
Phase 2 · China · 1 site
Registry update: 6 Aug 2025
NCT07123545
Recruiting
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
Phase 1/2 · China · 1 site
Registry update: 14 Aug 2025
NCT07113665
Recruiting
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder
Phase 1 · Canada · 1 site
Registry update: 14 Aug 2025
NCT06984822
Recruiting
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
Not applicable · Sweden · 2 sites
Registry update: 21 Nov 2025
NCT07323927
Recruiting
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
Early phase 1 · China · 1 site
Registry update: 7 Jan 2026
NCT06714123
Recruiting
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Phase 2 · Denmark, Estonia, United Kingdom · 5 sites
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.